Titre :
  • Bortezomib/docetaxel combination therapy in patients with anthracycline-pretreated advanced/metastatic breast cancer: a phase I/II dose-escalation study.
Auteur : Awada, Ahmad ; Albanell, J ; Canney, P A ; Dirix, Luc Y ; Gil, Thierry ; Cardoso, Fatima ; Gascon, P ; Piccart-Gebhart, Martine ; Baselga, J
Informations sur la publication : British Journal of Cancer, 98, 9, (page 1500-1507)
Statut de publication : Publié, 2008-05
Sujet CREF : Sciences bio-médicales et agricoles
Mots-clés : Anthracycline-pretreated
Bortezomib
Breast cancer
Docetaxel
Metastatic
Proteasome inhibitor
Mots-clés MeSH : Adult
Aged
Alopecia -- chemically induced
Anthracyclines -- administration & dosage
Antibiotics, Antineoplastic -- administration & dosage
Antineoplastic Combined Chemotherapy Protocols -- administration & dosage
Antineoplastic Combined Chemotherapy Protocols -- adverse effects
Antineoplastic Combined Chemotherapy Protocols -- pharmacokinetics
Antineoplastic Combined Chemotherapy Protocols -- therapeutic use
Belgium
Boronic Acids -- administration & dosage
Breast Neoplasms -- drug therapy
Breast Neoplasms -- pathology
Breast Neoplasms, Male -- drug therapy
Breast Neoplasms, Male -- pathology
Diarrhea -- chemically induced
Drug Administration Schedule
Female
Great Britain
Humans
Male
Middle Aged
Nausea -- chemically induced
Neutropenia -- chemically induced
Prospective Studies
Pyrazines -- administration & dosage
Spain
Taxoids -- administration & dosage
Treatment Outcome
Vomiting -- chemically induced
Note : Clinical Trial, Phase I
Clinical Trial, Phase II
Journal Article
Multicenter Study
Research Support, Non-U.S. Gov't
Langue :
  • Anglais
Identificateurs : urn:issn:0007-0920 
info:doi/10.1038/sj.bjc.6604347
info:pii/6604347
info:pmid/18454159
info:pmcid/PMC2391111